List of Tables:
Table 1. Snapshot of Global Pharmacovigilance and Drug Safety Software Market in Balanced Perspective, 2021-2031 20
Table 2. World Economic Outlook, 2021-2031 24
Table 3. World Economic Outlook, 2021-2023 25
Table 4. Main Product Trends and Market Opportunities in Global Pharmacovigilance and Drug Safety Software Market 37
Table 5. Global Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 45
Table 6. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, $ mn 51
Table 7. Global Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, $ mn 58
Table 8. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 65
Table 9. Global Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, $ mn 69
Table 10. Global Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 78
Table 11. Global Pharmacovigilance and Drug Safety Software Market by Region, 2021-2031, $ mn 85
Table 12. Leading National Pharmacovigilance and Drug Safety Software Market, 2021 and 2031, $ mn 87
Table 13. North America Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 90
Table 14. U.S. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 94
Table 15. U.S. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 94
Table 16. U.S. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 94
Table 17. Canada Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 96
Table 18. Canada Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 96
Table 19. Canada Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 96
Table 20. Mexico Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 98
Table 21. Mexico Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 98
Table 22. Mexico Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 98
Table 23. Europe Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 102
Table 24. Germany Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 104
Table 25. Germany Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 104
Table 26. Germany Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 104
Table 27. U.K. Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 106
Table 28. U.K. Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 106
Table 29. U.K. Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 106
Table 30. France Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 108
Table 31. France Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 108
Table 32. France Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 108
Table 33. Spain Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 110
Table 34. Spain Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 110
Table 35. Spain Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 110
Table 36. Italy Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 112
Table 37. Italy Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 112
Table 38. Italy Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 112
Table 39. Netherlands Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 114
Table 40. Netherlands Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 114
Table 41. Netherlands Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 114
Table 42. Pharmacovigilance and Drug Safety Software Market in Rest of Europe by Country, 2021-2031, $ mn 116
Table 43. APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 119
Table 44. Japan Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 123
Table 45. Japan Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 123
Table 46. Japan Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 123
Table 47. China Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 125
Table 48. China Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 125
Table 49. China Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 125
Table 50. Australia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 127
Table 51. Australia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 127
Table 52. Australia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 127
Table 53. India Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 129
Table 54. India Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 129
Table 55. India Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 129
Table 56. South Korea Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 131
Table 57. South Korea Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 131
Table 58. South Korea Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 131
Table 59. Pharmacovigilance and Drug Safety Software Market in Rest of APAC by Country/Region, 2021-2031, $ mn 133
Table 60. South America Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 136
Table 61. Argentina Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 138
Table 62. Argentina Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 138
Table 63. Argentina Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 138
Table 64. Brazil Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 140
Table 65. Brazil Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 140
Table 66. Brazil Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 140
Table 67. Chile Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 142
Table 68. Chile Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 142
Table 69. Chile Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 142
Table 70. MEA Pharmacovigilance and Drug Safety Software Market by Country, 2021-2031, $ mn 146
Table 71. UAE Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 148
Table 72. UAE Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 148
Table 73. UAE Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 148
Table 74. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 150
Table 75. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 150
Table 76. Saudi Arabia Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 150
Table 77. South Africa Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, $ mn 152
Table 78. South Africa Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, $ mn 152
Table 79. South Africa Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, $ mn 152
Table 80. Ab Cube: Company Snapshot 158
Table 81. Ab Cube: Business Segmentation 159
Table 82. Ab Cube: Product Portfolio 159
LIST OF FIGURE
List of Figures:
Figure 1. Research Method Flow Chart 14
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 17
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 19
Figure 4. Global Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 22
Figure 5. Impact of COVID-19 on Business 27
Figure 6. Primary Drivers and Impact Factors of Global Pharmacovigilance and Drug Safety Software Market 29
Figure 7. Percentage of Trial Participants by Country, 2015-2019 32
Figure 8. World Drug Discovery Market, 2019-2030, $ mn 33
Figure 9. Primary Restraints and Impact Factors of Global Pharmacovigilance and Drug Safety Software Market 34
Figure 10. Investment Opportunity Analysis 38
Figure 11. Porters Fiver Forces Analysis of Global Pharmacovigilance and Drug Safety Software Market 41
Figure 12. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Functionality, 2021-2031, % of Revenue 46
Figure 13. Global Addressable Market Cap in 2022-2031 by Functionality, Value ($ mn) and Share (%) 46
Figure 14. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Adverse Event Reporting Software, 2021-2031, $ mn 47
Figure 15. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Drug Safety Audits Software, 2021-2031, $ mn 48
Figure 16. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Issue Tracking Software, 2021-2031, $ mn 49
Figure 17. Global Pharmacovigilance and Drug Safety Software Market by Functionality: Fully Integrated Software, 2021-2031, $ mn 50
Figure 18. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase, 2021-2031, % of Sales Revenue 52
Figure 19. Global Addressable Market Cap in 2022-2031 by Clinical Phase, Value ($ mn) and Share (%) 52
Figure 20. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Pre-clinical, 2021-2031, $ mn 53
Figure 21. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase I, 2021-2031, $ mn 54
Figure 22. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase II, 2021-2031, $ mn 55
Figure 23. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase III, 2021-2031, $ mn 56
Figure 24. Global Pharmacovigilance and Drug Safety Software Market by Clinical Phase: Phase IV, 2021-2031, $ mn 57
Figure 25. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Method, 2021-2031, % of Sales Revenue 59
Figure 26. Global Addressable Market Cap in 2022-2031 by Method, Value ($ mn) and Share (%) 59
Figure 27. Global Pharmacovigilance and Drug Safety Software Market by Method: Spontaneous Reporting, 2021-2031, $ mn 60
Figure 28. Global Pharmacovigilance and Drug Safety Software Market by Method: Intensified ADR Reporting, 2021-2031, $ mn 61
Figure 29. Global Pharmacovigilance and Drug Safety Software Market by Method: Targeted Spontaneous Reporting, 2021-2031, $ mn 62
Figure 30. Global Pharmacovigilance and Drug Safety Software Market by Method: Cohort Event Monitoring, 2021-2031, $ mn 63
Figure 31. Global Pharmacovigilance and Drug Safety Software Market by Method: EHR Mining, 2021-2031, $ mn 64
Figure 32. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode, 2021-2031, % of Revenue 66
Figure 33. Global Addressable Market Cap in 2022-2031 by Delivery Mode, Value ($ mn) and Share (%) 66
Figure 34. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-premise Delivery, 2021-2031, $ mn 67
Figure 35. Global Pharmacovigilance and Drug Safety Software Market by Delivery Mode: On-demand Delivery, 2021-2031, $ mn 68
Figure 36. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by Indication, 2021-2031, % of Revenue 70
Figure 37. Global Addressable Market Cap in 2022-2031 by Indication, Value ($ mn) and Share (%) 70
Figure 38. Global Pharmacovigilance and Drug Safety Software Market by Indication: Oncology, 2021-2031, $ mn 71
Figure 39. Global Pharmacovigilance and Drug Safety Software Market by Indication: Respiratory Disorders, 2021-2031, $ mn 72
Figure 40. Global Pharmacovigilance and Drug Safety Software Market by Indication: Cardiology, 2021-2031, $ mn 73
Figure 41. Global Pharmacovigilance and Drug Safety Software Market by Indication: Neurology, 2021-2031, $ mn 74
Figure 42. Global Pharmacovigilance and Drug Safety Software Market by Indication: Immunology, 2021-2031, $ mn 75
Figure 43. Global Pharmacovigilance and Drug Safety Software Market by Indication: Pain Management, 2021-2031, $ mn 76
Figure 44. Global Pharmacovigilance and Drug Safety Software Market by Indication: Other Indications, 2021-2031, $ mn 77
Figure 45. Breakdown of Global Pharmacovigilance and Drug Safety Software Market by End User, 2021-2031, % of Revenue 78
Figure 46. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 79
Figure 47. Global Pharmacovigilance and Drug Safety Software Market by End User: Pharmaceutical and Biotechnology Companies, 2021-2031, $ mn 80
Figure 48. Global Pharmacovigilance and Drug Safety Software Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 81
Figure 49. Global Pharmacovigilance and Drug Safety Software Market by End User: Business Process Outsourcing Firms (BPOs), 2021-2031, $ mn 82
Figure 50. Global Pharmacovigilance and Drug Safety Software Market by End User: Other End Users, 2021-2031, $ mn 83
Figure 51. Global Market Snapshot by Region 84
Figure 52. Geographic Spread of Worldwide Pharmacovigilance and Drug Safety Software Market, 2021-2031, % of Sales Revenue 85
Figure 53. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 86
Figure 54. North American Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 89
Figure 55. Breakdown of North America Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 90
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 91
Figure 57. U.S. Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 93
Figure 58. Canada Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 95
Figure 59. Pharmacovigilance and Drug Safety Software Market in Mexico, 2021-2031, $ mn 97
Figure 60. European Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 100
Figure 61. Breakdown of European Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 101
Figure 62. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 102
Figure 63. Pharmacovigilance and Drug Safety Software Market in Germany, 2021-2031, $ mn 103
Figure 64. Pharmacovigilance and Drug Safety Software Market in U.K., 2021-2031, $ mn 105
Figure 65. Pharmacovigilance and Drug Safety Software Market in France, 2021-2031, $ mn 107
Figure 66. Pharmacovigilance and Drug Safety Software Market in Spain, 2021-2031, $ mn 109
Figure 67. Pharmacovigilance and Drug Safety Software Market in Italy, 2021-2031, $ mn 111
Figure 68. Pharmacovigilance and Drug Safety Software Market in Netherlands, 2021-2031, $ mn 113
Figure 69. Pharmacovigilance and Drug Safety Software Market in Rest of Europe, 2021-2031, $ mn 115
Figure 70. Asia-Pacific Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 118
Figure 71. Breakdown of APAC Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 118
Figure 72. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 120
Figure 73. Pharmacovigilance and Drug Safety Software Market in Japan, 2021-2031, $ mn 122
Figure 74. Pharmacovigilance and Drug Safety Software Market in China, 2021-2031, $ mn 124
Figure 75. Pharmacovigilance and Drug Safety Software Market in Australia, 2021-2031, $ mn 126
Figure 76. Pharmacovigilance and Drug Safety Software Market in India, 2021-2031, $ mn 128
Figure 77. Pharmacovigilance and Drug Safety Software Market in South Korea, 2021-2031, $ mn 130
Figure 78. Pharmacovigilance and Drug Safety Software Market in Rest of APAC, 2021-2031, $ mn 132
Figure 79. South America Pharmacovigilance and Drug Safety Software Market, 2021-2031, $ mn 135
Figure 80. Breakdown of South America Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 135
Figure 81. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 136
Figure 82. Pharmacovigilance and Drug Safety Software Market in Argentina, 2021-2031, $ mn 137
Figure 83. Pharmacovigilance and Drug Safety Software Market in Brazil, 2021-2031, $ mn 139
Figure 84. Pharmacovigilance and Drug Safety Software Market in Chile, 2021-2031, $ mn 141
Figure 85. Pharmacovigilance and Drug Safety Software Market in Rest of South America, 2021-2031, $ mn 143
Figure 86. Pharmacovigilance and Drug Safety Software Market in Middle East and Africa (MEA), 2021-2031, $ mn 145
Figure 87. Breakdown of MEA Pharmacovigilance and Drug Safety Software Market by Country, 2021 and 2031, % of Revenue 145
Figure 88. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 146
Figure 89. Pharmacovigilance and Drug Safety Software Market in UAE, 2021-2031, $ mn 147
Figure 90. Pharmacovigilance and Drug Safety Software Market in Saudi Arabia, 2021-2031, $ mn 149
Figure 91. Pharmacovigilance and Drug Safety Software Market in South Africa, 2021-2031, $ mn 151
Figure 92. Growth Stage of Global Pharmacovigilance and Drug Safety Software Industry over the Forecast Period 154
